In vitro reactivation of latent equid herpesvirus-1 from CD5+/CD8+ leukocytes indirectly by IL-2 or chorionic gonadotrophin.

This study investigates how the Interleukin-2 (IL-2) and equine chorionic gonadotrophin (eCG) can reactivate the equid herpesvirus-1 (EHV-1) in CD5+/CD8+ leukocytes from horses. Reactivation in this case implies a stimulation of the virus from its dormant state. This research offers insights into the cells that serve as hosts for EHV-1 in horses, and could offer new methods to detect and study the virus.

Study Background and Methodology

• The researchers examined how two substances, Interleukin-2 (IL-2) and equine chorionic gonadotrophin (eCG), could stimulate the reactivation of equid herpesvirus-1 (EHV-1).
• This reactivation was tested from venous lymphocytes at a frequency of 1/10(-5).
• The reactivation process was analyzed using indirect immunofluorescence, a technique used to visualize the distribution of proteins in cells.

Major Findings

• They found that more than 80% of virus-positive leukocytes were CD5+/CD8+ with the remaining 20% being CD5+/CD8-/CD4-.
• The reactivated virus was infectious when co-cultivated, confirming the successful reactivation process.
• Additionally, it was discovered that the virus can be reactivated in vitro from leukocytes of more than 70% of horses by the mitogens phytohaemagglutinin (PHA) and pokeweed mitogen (PWM).

A Closer Look at Reactivation Process

• The information suggests that IL-2 and eCG worked indirectly, inciting the release of other mediators from adherent cells. These mediators then reactivated EHV-1 from T cells.
• Further experiments blocking IL-2 demonstrate how PWM and PHA stimulate the virus via IL-2, but eCG does not follow this mechanism.
• This research gives the first clear define of the lymphoid cells that host latent EHV-1 in horses. The results coordinate with current RT-PCR and in situ hybridization of latency-associated transcripts in lymphocytes.

Implications and Future Directions

• The method of reactivation in vitro established in this research can be used to detect horses carrying latent EHV-1, providing a new diagnostic tool.
• Moreover, it also offers potential for further exploration of the sequence of events involved in the reactivation process in vitro, providing an experimental platform for potential future interventions and treatments.